Genetron Health is a world-leading expert in precision medicine. We are committed to developing health management products that cover all elements of full-cycle cancer clinical treatment (including risk assessment, early screening, molecular pathology ...Learn More
Chinese and American Cancer experts jointly issued recommendations
2 annual drug regimen update, matching new targeted drugs
4 professional medical consultants regularly followed up every yearLearn more
Genetron Health’s innovative research service team has extensive experience in genetics, genomics and bioinformatics with many high-quality research publications in major journals including the New England Journal of Medicine, Nature, Science and Nature Genetics. We work with individual customers to design exciting scientific projects and provide first-class genome research technologies with personalized and comprehensive bioinformatic analysis.Learn more
Genetron Health has the most advanced detection platform, comprehensive and diverse, can quickly and accurately according to clinical samples of various types of nucleic acid and protein detection, provide strong support for cancer genomics research and clinical application: two generation sequencing (NGS), generation sequencing (Sanger) and digital PCR (dPCR), fluorescence quantitative PCR (qPCR), pyrosequencing (Pyrose-quencing), fluorescence capillary electrophoresis, fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). Equipment including Novoseq 6000，HiSeq X Ten，HiSeq 4000，MiSeq，NextSeq， QuantStudio，RainDance，PyroMark, etc..
Genetron Health leading information analysis platform, computing architecture of data center security development based on cloud, and with independent intellectual property rights information analysis software to analyze the complete large-scale genomics data storage. At the same time, Genetron Health has a plurality of synchronization with the international cancer genome database, can be timely and effective access to international cancer research field, the integration of the world's new gene mutation and drug target information, to provide the best service for the cancer genome analysis partners.
The tumor tissue samples can be obtained in clinical samples are limited, the quality and success rate of sample processing will directly affect the subsequent sequencing results and data analysis results. Genetron Health clinical sample processing platform, built by domestic and foreign deep clinical and experimental experts, different treatment for different types of samples, can guarantee to all kinds of clinical samples are the most effective treatment, ensure the accuracy and specificity of detection results.
Genetron Health technology innovation team, team members have many years of clinical and basic science research experience, a large number of high-quality academic articles (Science, Nature, New England Journal of Medicine) published scientific research experience, can help partners to design the overall research project, according to the different schemes to provide services for the analysis of data quality, accelerate the scientific research output.